Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy

Cystic fibrosis (CF) patients receive repeated courses of aminoglycoside therapy. These patients would consequently be expected to be more susceptible to cochleotoxicity, a recognized side effect with single courses of aminoglycoside therapy. The primary aim of this retrospective study was to establ...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Mulheran, M., Degg, C., Burr, S., Morgan, D. W., Stableforth, D. E.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2001
Soggetti:	Clinical Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11502521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.9.2502-2509.2001
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!